Disease risk scores for skin cancers

被引:0
|
作者
Pierre Fontanillas
Babak Alipanahi
Nicholas A. Furlotte
Michaela Johnson
Catherine H. Wilson
Steven J. Pitts
Robert Gentleman
Adam Auton
机构
[1] 23andMe Inc.,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We trained and validated risk prediction models for the three major types of skin cancer— basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma—on a cross-sectional and longitudinal dataset of 210,000 consented research participants who responded to an online survey covering personal and family history of skin cancer, skin susceptibility, and UV exposure. We developed a primary disease risk score (DRS) that combined all 32 identified genetic and non-genetic risk factors. Top percentile DRS was associated with an up to 13-fold increase (odds ratio per standard deviation increase >2.5) in the risk of developing skin cancer relative to the middle DRS percentile. To derive lifetime risk trajectories for the three skin cancers, we developed a second and age independent disease score, called DRSA. Using incident cases, we demonstrated that DRSA could be used in early detection programs for identifying high risk asymptotic individuals, and predicting when they are likely to develop skin cancer. High DRSA scores were not only associated with earlier disease diagnosis (by up to 14 years), but also with more severe and recurrent forms of skin cancer.
引用
收藏
相关论文
共 50 条
  • [11] Risk perception of skin cancers in primary care
    Cavallo, Francesco
    Avallone, Gianluca
    Tromellini, Anna G.
    Quaglino, Pietro
    Ribero, Simone
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (01) : 64 - 64
  • [13] Are military personnel at a more risk for skin cancers?
    Durmishi, Amarildo
    Fida, Monika
    Hoxha, Sindi
    Naqo, Xhuljeta
    Bardhi, Brunilda
    Xhelili, Malbora
    Vasili, Ermira
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [14] Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients
    Rodrigues, Michelle
    DERMATOLOGIC CLINICS, 2017, 35 (02) : 129 - +
  • [15] Polygenic Risk Scores in Human Disease
    Maamari, Dimitri J.
    Abou-Karam, Roukoz
    Fahed, Akl C.
    CLINICAL CHEMISTRY, 2025, 71 (01) : 69 - 76
  • [16] The risk of lymphoproliferative disorders and skin cancers in patients with psoriasis and inflammatory bowel disease administered biologics
    Jung, J.
    Choi, E.
    Kim, G.
    Chang, S.
    Lee, M.
    Won, C.
    Lee, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S77 - S77
  • [17] The Risk of Lymphoproliferative Disorders and Skin Cancers in Patients with Psoriasis and Inflammatory Bowel Disease Administered Biologics
    Jung, Joon Min
    Kim, Ye-Jee
    Chang, Sung Eun
    Lee, Mi Woo
    Won, Chong Hyun
    Lee, Woo Jin
    DERMATOLOGIC THERAPY, 2023, 2023
  • [18] Risk of Nonmelanoma Skin Cancers and Parkinson's Disease-Meta-Analysis and Systematic Review
    Krasowska, Danuta
    Gerkowicz, Agnieszka
    Mlak, Radoslaw
    Leziak, Milena
    Malecka-Massalska, Teresa
    Krasowska, Dorota
    CANCERS, 2021, 13 (04) : 1 - 13
  • [19] Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
    Peyrin-Biroulet, Laurent
    Khosrotehrani, Kiarash
    Carrat, Fabrice
    Bouvier, Anne-Marie
    Chevaux, Jean-Baptiste
    Simon, Tabassome
    Carbonnel, Frank
    Colombel, Jean-Frederic
    Dupas, Jean-Louis
    Godeberge, Philippe
    Hugot, Jean-Pierre
    Lemann, Marc
    Nahon, Stephane
    Sabate, Jean-Marc
    Tucat, Gilbert
    Beaugerie, Laurent
    GASTROENTEROLOGY, 2011, 141 (05) : 1621 - U150
  • [20] MULTIPLE SEQUENTIAL SKIN CANCERS - RISK OF SKIN CANCER IN PATIENTS WITH PREVIOUS SKIN CANCER
    BIRO, L
    PRICE, E
    ARCHIVES OF DERMATOLOGY, 1976, 112 (10) : 1470 - 1470